TradingKey

關於 Insulet Corp 公司

Insulet Corporation 是一家醫療設備公司。該公司主要從事爲胰島素依賴型糖尿病患者開發、製造和銷售其持續胰島素輸送系統。Omnipod 系統包括 Omnipod 5 自動胰島素輸送系統 (Omnipod 5)、Omnipod DASH 胰島素管理系統、Omnipod 胰島素管理系統和 Omnipod GO。該公司還爲安進公司生產用於 Neulasta Onpro 套件的膠囊，該套件是安進公司 Neulasta 的輸送系統。Omnipod 平臺提供持續胰島素輸送，可提供胰島素泵治療的各種益處，而無需傳統泵所需的外部管道。小巧、輕便、自粘式一次性無管 Omnipod 設備 (Pod) 可佩戴在多個位置，包括腹部、臀部、上臂後部、大腿上部或下背部，並通過小型柔性管將胰島素輸送到體內。Omnipod 5 包括嵌入在 Pod 中的 AID 算法。

公司簡介

公司代碼PODD

公司名稱Insulet Corp

上市日期May 15, 2007

成立日期2000

CEOMs. Ashley Mcevoy

員工數量3900

證券類型Ordinary Share

年結日May 15

公司地址100 Nagog Park

城市ACTON

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編01720-3440

電話19786007000

網址https://www.omnipod.com

公司代碼PODD

上市日期May 15, 2007

成立日期2000

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

16.23K

+5.03%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

--

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238500.00%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

Mr. Prem Singh

Senior Vice President - Global Operations

4.25K

-20.11%

Ms. Laetitia Cousin

Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance

3.58K

+24.38%

Dr. Luciana Borio, M.D.

Independent Director

3.09K

-13.48%

Mr. Timothy C. (Tim) Stonesifer

Independent Director

2.89K

+36.78%

名稱

名稱/職務

職務

持股

持股變動

Dr. Jessica Hopfield, Ph.D.

Independent Director

27.70K

+2.89%

Mr. Michael R. Minogue

Independent Director

16.23K

+5.03%

Mr. Eric Benjamin

Executive Vice President, Chief Product and Customer Experience Officer

14.73K

--

Ms. Ashley Mcevoy

President, Chief Executive Officer, Director

9.54K

+238500.00%

Ms. Elizabeth H. (Bess) Weatherman

Independent Director

5.24K

+17.43%

Ms. Lauren Budden

Chief Accounting Officer, Group Vice President, Corporate Controller

5.22K

+17.01%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

業務USD

名稱

營收

佔比

U.S.Omnipod

401.70M

70.60%

International Omnipod

152.40M

26.78%

Drug Delivery

14.90M

2.62%

地區USD

名稱

營收

佔比

United States

416.60M

73.22%

All Other

152.40M

26.78%

業務

地區

業務USD

名稱

營收

佔比

U.S.Omnipod

401.70M

70.60%

International Omnipod

152.40M

26.78%

Drug Delivery

14.90M

2.62%

股東統計

更新時間: 5月16日週五

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

12.28%

Fidelity Management & Research Company LLC

10.13%

Capital Research Global Investors

8.64%

BlackRock Institutional Trust Company, N.A.

6.20%

State Street Global Advisors (US)

4.30%

Other

58.46%

持股股東

佔比

The Vanguard Group, Inc.

12.28%

Fidelity Management & Research Company LLC

10.13%

Capital Research Global Investors

8.64%

BlackRock Institutional Trust Company, N.A.

6.20%

State Street Global Advisors (US)

4.30%

Other

58.46%

股東類型

持股股東

佔比

Investment Advisor

67.95%

Investment Advisor/Hedge Fund

23.98%

Hedge Fund

3.39%

Research Firm

2.94%

Pension Fund

1.77%

Sovereign Wealth Fund

1.43%

Bank and Trust

1.38%

Individual Investor

0.29%

Private Equity

0.10%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

1531

72.76M

103.41%

-3.63M

2025Q1

1569

72.82M

103.50%

-3.52M

2024Q4

1508

72.57M

103.34%

-4.94M

2024Q3

1436

73.14M

104.31%

-3.15M

2024Q2

1408

72.17M

103.04%

-3.02M

2024Q1

1350

71.60M

102.26%

-3.12M

2023Q4

1320

72.91M

104.42%

-1.52M

2023Q3

1254

72.05M

103.19%

-4.06M

2023Q2

1223

73.42M

105.35%

-3.44M

2023Q1

1206

74.71M

107.20%

-300.49K

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

8.64M

12.28%

+178.96K

+2.12%

Mar 31, 2025

Fidelity Management & Research Company LLC

7.13M

10.13%

+45.85K

+0.65%

Mar 31, 2025

Capital Research Global Investors

6.08M

8.64%

-1.37M

-18.40%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

4.36M

6.2%

+115.38K

+2.72%

Mar 31, 2025

State Street Global Advisors (US)

3.02M

4.3%

+49.05K

+1.65%

Mar 31, 2025

Baillie Gifford & Co.

2.25M

3.2%

-104.93K

-4.45%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.87M

2.66%

+90.07K

+5.06%

Mar 31, 2025

ClearBridge Investments, LLC

1.48M

2.1%

+73.68K

+5.24%

Mar 31, 2025

Fidelity International

1.29M

1.83%

-146.07K

-10.21%

Mar 31, 2025

American Century Investment Management, Inc.

1.15M

1.64%

+297.73K

+34.83%

Mar 31, 2025

持股ETF

更新時間: 7月6日週日

機構名稱

佔比

Langar Global HealthTech ETF

6.37%

Global X HealthTech ETF

4.95%

Fidelity Digital Health ETF

4.92%

First Trust Nasdaq Lux Digi Health Solutions ETF

4.85%

Goldman Sachs Future Health Care Equity ETF

4.69%

Congress SMid Growth ETF

3.43%

Nuveen ESG Mid-Cap Growth ETF

2.85%

iShares Health Innovation Active ETF

2.73%

FT Raymond James Multicap Growth Equity ETF

2.64%

First Trust Health Care Alphadex Fund

2.61%

Langar Global HealthTech ETF

佔比6.37%

Global X HealthTech ETF

佔比4.95%

Fidelity Digital Health ETF

佔比4.92%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比4.85%

Goldman Sachs Future Health Care Equity ETF

佔比4.69%

Congress SMid Growth ETF

佔比3.43%

Nuveen ESG Mid-Cap Growth ETF

佔比2.85%

iShares Health Innovation Active ETF

佔比2.73%

FT Raymond James Multicap Growth Equity ETF

佔比2.64%

First Trust Health Care Alphadex Fund

佔比2.61%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Insulet Corp

284.830USD

Insulet Corp

284.830

概覽

公司

財務